Newsletter | March 5, 2024

03.05.24 -- AI's Role In Advancing Rare Disease Research

SPONSOR

Webinar: Never Miss A Signal — Building An Analytics Culture In Clinical Development

We’ll discuss what challenges pharmaceutical and biotech companies face when selecting a good data management solution that is cost-effective, efficient, and drives clinical decision-making and clinical trial strategy. We’ll cover how SaaS and data management can accelerate clinical trial data preparation, and how data management can partner with clinical teams to drive trial execution and clinical decision-making. Click here to learn more.

CLINICAL TRIAL TECHNOLOGY

AI Tools Advancing Rare Disease Research

IndoUSrare experts explore the global issues in rare disease research and examine how AI is poised to revolutionize the diagnosis and treatment of these often-overlooked conditions.

Implementing eSource: A Guide For Operations And Technology Roles

By recognizing and addressing the challenges associated with eSource integration, research facilities can fully harness its transformative potential, optimizing efficiency and reliability.

7 eCOA Design Recommendations: Insights From Sites And CRAs

Signant joined a group of C-Path members, including other eCOA solutions providers, sponsors, and regulators, for a GBTI project that revealed several opportunities to improve eCOA usability and flexibility.

Zero Disruptions: Migrating 14 Midstudy Clinical Trials In 16 Months

Uncover how Imperial College London was able to effectively transfer 14 ongoing studies, encompassing over 1,700 patients and 150,000+ forms, onto a new EDC platform within 16 months.

The Essential Role Of Adjudication Technology In Clinical Trials

With adjudication, learn how teams can enhance the quality and integrity of their research, paving the way for impactful and reliable outcomes in clinical research.

Efficiency, Flexibility, And Speed: Building Better Clinical Trials

Zelta’s EDC has been used in more than 4,000 studies from startup to submission, across all phases, including over 500 Phase 3c trials and 23 therapeutic areas.

Subject Creation With eCOA, eConsent, And IRT Process Flow

Watch to see how IQVIA’s integrated interactive response technology and electronic clinical outcome assessment solution combined with unified platform delivery drives study orchestration and optimization.

CHOOSE YOUR OWN ADVENTURE

You're receiving the Tuesday edition of the Clinical Leader newsletter, focusing on Clinical Trial Technology. To make changes to your newsletter selections, update your topic preferences.

  • Clinical Sites | Patient Centricity | Patient Recruitment (Monday)
  • Clinical Trial Technology (Tuesday)
  • Decentralized Trials | Trial Management (Wednesday)
  • Outsourcing Models | Regulatory & Compliance (Thursday)
  • Clinical Data Management & Analytics | Trial Monitoring (Friday)

Learn more about our personalized newsletters here.

Connect With Clinical Leader: